Skip to content
Menu
Network
Sub-Menu
Browse by Subject
Browse by Publisher
Join the Network
Get Started
Subscribe
Support
Contact
Search
Close
Enter Search Terms
Search
Anjali Jenna (AJ) Teigen
ID:
1b83c145-2619-30fb-68c4
/
Claimed Record
/
Organization:
Rothwell Figg
Published Works
26 articles
IP Assignment Considerations for Emerging Companies
RF EMerge ·
March 26, 2021
cite
The USPTO Clarifies its Approach to Indefiniteness in AIA Post-Grant Proceedings
PTAB Law Blog ·
February 12, 2021
cite
The New Exclusive European Licensee of Cenobamate: Angelini Pharma Acquires Emerging Swiss Biotech Company Arvelle Therapeutics
RF EMerge ·
January 7, 2021
cite
FDA’s New Draft Guidance Regarding Biosimilarity and Interchangeability
Biosimilars Law Bulletin ·
December 8, 2020
cite
Will The USPTO Codify Its Discretionary Determination Of Deciding Whether To Institute AIA Trials?
PTAB Law Blog ·
November 30, 2020
cite
Previous
1
2
3
4
5
6
Next
Practice Areas
Health Care and Life Sciences
Privacy and Cybersecurity
Intellectual Property
Business and Commercial
Jurisdictions
North America
United States
Washington, D.C.
